Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TOP2A | P11388 | 1/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5278791 | 0.90 | SLC9A1 (0.37) | SLC9A1ALDH1A1TOP2AHCAR3SMN1; SMN2 | |
| SCHEMBL5275930 | 0.88 | SMN1; SMN2 (0.39) | SLC9A1ALDH1A1TOP2AGRIA4HCAR3 | |
| SCHEMBL5274445 | 0.87 | SLC9A1 (0.40) | SLC9A1ALDH1A1TOP2AHCAR3 | |
| SCHEMBL5276637 | 0.86 | NPC1 (0.33) | SLC9A1ALDH1A1 | |
| SCHEMBL5278499 | 0.85 | SMN1; SMN2 (0.32) | SLC9A1ALDH1A1TOP2ASMN1; SMN2 | |
| SCHEMBL5281297 | 0.84 | ALDH1A1 (0.31) | SLC9A1ALDH1A1TOP2A | |
| SCHEMBL5282075 | 0.84 | GRIA4 (0.34) | SLC9A1ALDH1A1TOP2AGRIA4 | |
| SCHEMBL5283087 | 0.81 | GRM2 (0.38) | SLC9A1ALDH1A1TOP2AGRIA4HCAR3 | |
| SCHEMBL5285281 | 0.81 | ALDH1A1 (0.36) | SLC9A1ALDH1A1TOP2AGRIA4HCAR3 | |
| SCHEMBL5279828 | 0.81 | SLC9A1 (0.35) | SLC9A1ALDH1A1TOP2AGRIA4HCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1859781-A2 | Brightening and/or colouring agent with triazoles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-11-28 | — | — | EP | disclosed |